Telesis Bio, Inc. (TBIO)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0120
 0.00 (0.00%)
  Oct 31, 2025, 3:00 PM EST
Telesis Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
 Millions USD. Fiscal year is Jan - Dec.
Fiscal Year  | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 
|---|---|---|---|---|---|---|
Period Ending  | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 
Cash & Equivalents     | 3.72 | 1.57 | 30.42 | 82.81 | 13.46 | 29.14 | 
Short-Term Investments     | 0.79 | 17.59 | 13.16 | - | - | - | 
Cash & Short-Term Investments     | 4.51 | 19.16 | 43.58 | 82.81 | 13.46 | 29.14 | 
Cash Growth     | -89.11% | -56.04% | -47.37% | 515.06% | -53.80% | - | 
Receivables     | 1.26 | 5.99 | 5.85 | 3.67 | 2.27 | 1.49 | 
Inventory     | 1.1 | 4.03 | 2.2 | 2.37 | 0.6 | 0.71 | 
Prepaid Expenses     | 1.1 | 1.01 | 3.29 | 4.35 | 0.85 | 0.09 | 
Restricted Cash     | 0.1 | 0.18 | 0.18 | - | - | - | 
Total Current Assets     | 8.12 | 30.35 | 55.09 | 93.18 | 17.18 | 31.43 | 
Property, Plant & Equipment     | 11.99 | 34.52 | 8.52 | 5.74 | 3.78 | 0.89 | 
Goodwill     | 3.5 | 3.5 | 14.89 | 14.33 | 3.5 | 3.5 | 
Other Intangible Assets     | 0.64 | 1.37 | 1.88 | 2.4 | 2.33 | 2.86 | 
Other Long-Term Assets     | 0.49 | 0.68 | 0.98 | 0.61 | 0.08 | 0.08 | 
Total Assets     | 24.74 | 70.41 | 81.36 | 116.26 | 26.86 | 38.76 | 
Accounts Payable     | 1.49 | 3.28 | 1.3 | 2.5 | 1.19 | 0.61 | 
Accrued Expenses     | 1.93 | 2.65 | 7.24 | 4.85 | 1.69 | 0.89 | 
Current Portion of Long-Term Debt     | - | - | - | 0.6 | 1.33 | - | 
Current Portion of Leases     | 2.21 | 1.82 | 0.64 | 1.24 | 0.78 | 0.11 | 
Current Unearned Revenue     | 0.26 | 0.34 | 3.96 | 0.21 | 0.61 | 0.11 | 
Other Current Liabilities     | 0.74 | 0.09 | 0.37 | 0.34 | 0.02 | - | 
Total Current Liabilities     | 6.63 | 8.18 | 13.5 | 9.73 | 5.63 | 1.72 | 
Long-Term Debt     | 5.84 | 5.27 | 19.65 | 14.09 | 3.35 | 4.47 | 
Long-Term Leases     | 8.25 | 27.29 | 1.14 | 1.39 | 2.86 | 0.19 | 
Long-Term Unearned Revenue     | 0.15 | 0.1 | 0.14 | 0.15 | 0.04 | 0.03 | 
Other Long-Term Liabilities     | - | 0.04 | 0.37 | 0.11 | 1.53 | 0.94 | 
Total Liabilities     | 20.86 | 40.87 | 34.8 | 25.47 | 13.41 | 7.35 | 
Common Stock     | - | 0.01 | 0.01 | 0.01 | 0 | 0 | 
Additional Paid-In Capital     | 162.11 | 161.7 | 160.3 | 156.05 | 0.85 | 0.8 | 
Retained Earnings     | -189.33 | -161.47 | -113.74 | -65.27 | -26.31 | -8.3 | 
Comprehensive Income & Other     | -0.01 | - | -0 | - | - | - | 
Total Common Equity     | -27.22 | 0.24 | 46.57 | 90.78 | -25.46 | -7.5 | 
Shareholders' Equity     | 3.87 | 29.54 | 46.57 | 90.78 | 13.46 | 31.41 | 
Total Liabilities & Equity     | 24.74 | 70.41 | 81.36 | 116.26 | 26.86 | 38.76 | 
Total Debt     | 16.29 | 34.38 | 21.43 | 17.32 | 8.33 | 4.77 | 
Net Cash (Debt)     | -11.78 | -15.22 | 22.15 | 65.48 | 5.14 | 24.38 | 
Net Cash Growth     | - | - | -66.17% | 1174.75% | -78.93% | - | 
Net Cash Per Share     | -6.89 | -9.18 | 13.53 | 64.68 | 18.49 | 87.75 | 
Filing Date Shares Outstanding     | 1.78 | 1.67 | 1.65 | 1.63 | 0.28 | 0.28 | 
Total Common Shares Outstanding     | 1.77 | 1.67 | 1.65 | 1.63 | 0.28 | 0.28 | 
Working Capital     | 1.49 | 22.17 | 41.59 | 83.45 | 11.56 | 29.71 | 
Book Value Per Share     | -15.35 | 0.14 | 28.27 | 55.74 | -91.21 | -27.01 | 
Tangible Book Value     | -31.36 | -4.63 | 29.8 | 74.06 | -31.28 | -13.86 | 
Tangible Book Value Per Share     | -17.69 | -2.77 | 18.09 | 45.47 | -112.07 | -49.90 | 
Machinery     | 7 | 9.86 | 7.24 | 2.62 | 1.32 | 1.25 | 
Construction In Progress     | 0.06 | 0.59 | 1.5 | 1.54 | 0.1 | - | 
Leasehold Improvements     | 0.12 | 0.33 | 0.06 | 0.1 | 0.03 | - | 
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.